The phenotypic manifestations of complex developing systems are products of influences from genes, environments, interactions among genes, and interactions between genes and environments.
Many findings (loci, genes and interactions) have experimental support from previous studies while novel findings may define unknown genetic pathways for this complex disease.
Several issues arise in the analysis of experimental data related to gene function: on the one hand, the nature of measurement processes generates highly noisy signals; on the other hand, there are far more variables involved (number of genes and interactions among them) than experimental samples.
Now in YDHS, we have combined multiple tools under one resource that enables the user to e.g. browse through haplogroups and focus on certain SNPs distinct to that haplogroup and reveal where they are located and whether they have a link to a disease or condition and view the related genes and interactions.
Genetic explanations of development (Section 3.1), similar to what is seen in molecular genetics, work by identifying changes in the expression of genes and interactions among their RNA and protein products that lead to changes in the properties of morphological features during ontogeny (e.g., shape or size), while holding a variety of contextual variables fixed.
The total number of genes and interactions in each of the three databases is shown in Table 1.
A similar analysis [17] has shown that although genes and interactions between them evolve by duplication, the network motifs themselves are not direct products of duplication with inheritance.
It is to be noted that miRNA research is a rapidly expanding field and the list of genes and interactions are constantly evolving with an increase in publications.
We identified single nucleotide polymorphisms (SNP) in 36 candidate inflammatory genes and interactions among these SNPs that likely play a role in the overall risk for TT.
We have predicted novel molecular regulators (unique genes and interactions) which could have an impact on the pathophysiology of T2D and its complications via various significant pathways such as insulin signalling, oxidative metabolism, Wnt signalling and others.
This observed difference in effect on outcome, which may reflect the result of natural experiments by the tumor, may also prove important in prioritizing which genes and interactions might be most productively targeted to improve outcome.
